Vimentin Biomarker Research: Antibody Tools to Characterize VIMhigh Immunosuppressive Macrophages in Hepatocellular Carcinoma Microenvironment

Molecular Architecture and Core Cellular Functions of Vimentin Intermediate Filament Protein

Vimentin belongs to type III intermediate filament (IF) proteins selectively enriched within mesenchymal-derived cell populations across mammalian tissue systems. Its monomeric polypeptide contains a conserved central α-helical rod domain flanked by disordered N-terminal head and C-terminal tail segments, with a unique lectin-like motif embedded in rod II subdomain. Monomers sequentially assemble into dimers, tetramers and unit-length filaments before polymerizing into mature cytoskeletal networks linked to nuclear envelopes, endoplasmic reticulum and mitochondrial membranes. This structural framework sustains cellular morphology, directs front-rear polarity during migratory movement and organizes lamellipodial protrusions for cell motility regulation. Vimentin also mediates protein-protein interactions to shield SCRIB adaptor molecules from proteasomal degradation and stabilizes their anchoring to intermediate filament scaffolds under cellular stress conditions. Dynamic shifts in intracellular vimentin abundance mark epithelial-mesenchymal transition (EMT) and polarized macrophage functional reprogramming within heterogeneous tumor microenvironments.

Landmark Nature Cancer Study: VIMhigh Macrophages Drive HCC Immune Suppression via IL-1β Signaling

A September 2024 research publication in Nature Cancer (Impact Factor = 23.5) from Fudan University’s Wang Hongyang and Chen Lei research teams mapped spatial single-cell proteomic landscapes across archived human hepatocellular carcinoma (HCC) biospecimens. The research cohort integrated transcriptomic, spatial proteomic and in vitro co-culture datasets to dissect immune cell spatial crosstalk patterns within liver tumor microdomains. Multi-cohort correlation analysis captured consistent spatial co-localization between vimentin-high (VIMhigh) tumor-associated macrophages (TAMs) and FOXP3+ regulatory T cell populations across eight independent HCC patient subgroups. Ligand-receptor interactome profiling identified IL-1β and IFN-γ as primary paracrine mediators linking VIMhigh macrophages to amplified Treg suppressive functionality. Flow cytometry sorting stratified primary macrophage isolates by vimentin expression intensity; quantitative ELISA measurements recorded drastically elevated IL-1β secretion in VIMhigh subsets relative to VIMlow counterparts. Transwell co-culture functional validation confirmed that neutralizing IL-1β antibody treatment fully abrogated macrophage-induced IL-10 overproduction in Treg lymphocytes, verifying IL-1β as the core effector cytokine mediating HCC immune tolerance cascades.

Multi-Omics Experimental Workflows for VIMhigh Macrophage Mechanism Research

Three interconnected assay pipelines support systematic characterization of vimentin-expressing macrophage populations in HCC basic research projects. Spatial proteomics and single-cell RNA sequencing simultaneously quantify vimentin transcript and protein gradients while mapping adjacent immune cell spatial distribution within FFPE liver tissue sections. Primary macrophage isolation via flow cytometry utilizes fluorophore-conjugated anti-vimentin antibodies to separate VIMhigh and VIMlow subpopulations for cytokine secretion quantification and intracellular signaling profiling. Co-culture functional assays co-culture sorted macrophage subsets with purified Treg cells to measure IL-10, TGF-β and checkpoint molecule expression shifts under differential vimentin expression conditions. Orthogonal validation via western blot, immunocytochemistry and multiplex immunofluorescence confirms vimentin subcellular localization and relative abundance across macrophage polarization states. All experimental pipelines rely on high-specificity anti-vimentin recombinant antibodies to eliminate off-target mesenchymal cell background signals during quantitative biomarker detection.

Standardized Multi-Platform Validation Data of Anti-Vimentin Recombinant Rabbit mAb

ANT BIO PTE. LTD. S-RMab® Vimentin Recombinant Rabbit mAb (Catalog S0B2254, SDT-029-120) undergoes complete cross-assay functional verification for human cell and tissue sample detection workflows. Western blot analysis utilizing 1:500 primary dilution generates single sharp bands near the 57 kDa molecular weight marker in Daudi, HeLa and A549 whole cell lysates, consistent with the predicted 54 kDa vimentin polypeptide mass. Immunohistochemical staining on FFPE HCC tissue delivers crisp membranous and cytoplasmic labeling of stromal and tumor-associated macrophage populations with minimal non-specific nuclear background noise. Immunocytochemistry on fixed HeLa monolayers incubated at 1/250 dilution reveals distinct filamentous cytoskeletal vimentin signals co-stainable with tubulin and DAPI nuclear counterstain for multi-color subcellular localization imaging. All validation batches utilize HRP or Alexa Fluor® 488 conjugated anti-rabbit secondary reagents to maintain consistent signal linearity across low and high vimentin expression cell populations.

Core Fundamental Research Applications of ANT BIO PTE. LTD. Anti-Vimentin Antibody

FFPE hepatocellular carcinoma tissue microarray IHC quantifies VIMhigh macrophage density to stratify experimental cohorts for immune modulator compound screening campaigns. Multi-color immunofluorescence co-staining pairs anti-vimentin with FOXP3 and CD68 markers to map spatial Treg-macrophage crosstalk within heterogeneous liver tumor microdomains. Western blot analysis tracks dynamic vimentin abundance shifts following IL-4, IL-13 or tumor spheroid co-culture-induced macrophage polarization cycles. Flow cytometry immunophenotyping sorts VIMhigh and VIMlow primary TAM subsets for downstream cytokine ELISA and transcriptomic sequencing assays. Immunoprecipitation workflows isolate vimentin-SCRIB protein complexes to dissect intermediate filament-dependent proteasome resistance mechanisms. Spatial proteomics sample preparation utilizes unconjugated anti-vimentin antibodies for photocleavable barcode probe conjugation in GeoMx DSP tissue profiling workflows.

ANT BIO PTE. LTD. Tumor Immune Biomarker Recombinant Antibody Portfolio

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANT BIO PTE. LTD., we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.